Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.8K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.8K
T Cell Types and Functions01:24

T Cell Types and Functions

3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TIM3 is a context-dependent coregulator of cytotoxic T cell function.

Science signaling·2025
Same author

Tumor cell spheroid-induced suppression of primary human cytotoxic T cells as a scalable <i>in vitro</i> model of exhaustion.

Immunotherapy advances·2025
Same author

Correction: WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome.

Journal of hematology & oncology·2025
Same author

Targeting the SARS-CoV-2 reservoir in long COVID.

The Lancet. Infectious diseases·2025
Same author

WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome.

Journal of hematology & oncology·2025
Same author

Aging and inflammation limit the induction of SARS-CoV-2-specific CD8+ T cell responses in severe COVID-19.

JCI insight·2025

Related Experiment Video

Updated: Mar 14, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.6K

CD8+ T-cell specificity is compromised at a defined MHCI/CD8 affinity threshold.

Tamsin Dockree1, Christopher J Holland2, Mathew Clement1

  • 1Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.

Immunology and Cell Biology
|September 28, 2016
PubMed
Summary

Altering the CD8 co-receptor's binding to peptide-MHC class I (pMHCI) can significantly boost T-cell sensitivity. However, exceeding an affinity threshold compromises antigen specificity, impacting CD8+ T-cell immunity and therapies.

More Related Videos

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

9.2K
Author Spotlight: Optimized Protocol for Detecting Antigen-Specific T Cells in Mouse Lungs Using Tetramers
09:15

Author Spotlight: Optimized Protocol for Detecting Antigen-Specific T Cells in Mouse Lungs Using Tetramers

Published on: July 19, 2024

1.9K

Related Experiment Videos

Last Updated: Mar 14, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.6K
Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

9.2K
Author Spotlight: Optimized Protocol for Detecting Antigen-Specific T Cells in Mouse Lungs Using Tetramers
09:15

Author Spotlight: Optimized Protocol for Detecting Antigen-Specific T Cells in Mouse Lungs Using Tetramers

Published on: July 19, 2024

1.9K

Area of Science:

  • Immunology
  • Molecular Biology
  • Biophysics

Background:

  • The CD8 co-receptor is crucial for CD8+ T-cell immunity, enhancing sensitivity to antigen-driven activation through interaction with peptide-MHC class I (pMHCI) molecules.
  • This interaction occurs at a site distinct from the T-cell receptor (TCR) binding platform, modulating the threshold for T-cell activation.
  • Even minor increases in pMHCI/CD8 interaction strength can disproportionately amplify antigen sensitivity, but higher affinities risk losing recognition specificity.

Purpose of the Study:

  • To investigate the relationship between pMHCI/CD8 binding affinity and TCR-mediated antigen specificity.
  • To determine the affinity threshold at which antigen recognition is maintained.
  • To explore the potential for engineering CD8-binding properties to enhance adoptive T-cell transfer efficacy.

Main Methods:

  • Utilized a panel of MHC class I (MHCI) mutants engineered to possess altered CD8-binding properties.
  • Assessed the impact of varying pMHCI/CD8 affinities on TCR-mediated antigen specificity and T-cell activation sensitivity.
  • Quantified the biophysical parameters of pMHCI/CD8 interactions.

Main Results:

  • Demonstrated that TCR-mediated antigen specificity is contingent upon a defined pMHCI/CD8 affinity threshold.
  • Showed that small increases in pMHCI/CD8 interaction strength (~1.5-fold) can enhance antigen sensitivity significantly (up to two orders of magnitude).
  • Found that substantially higher affinities (~10-fold) lead to a complete loss of recognition specificity.

Conclusions:

  • CD8 co-receptor binding affinity to pMHCI plays a critical role in maintaining antigen specificity.
  • Engineering CD8-binding properties within specific biophysical limits can enhance T-cell sensitivity without sacrificing specificity.
  • These findings suggest a strategy for improving the therapeutic efficacy of adoptive T-cell transfer by optimizing CD8/pMHCI interactions.